222 results on '"Haass-Koffler, Carolina L."'
Search Results
2. Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies
3. Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding protein
4. Neuroscience targets and human studies: future translational efforts in the stress system
5. An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder
6. Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy
7. Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations
8. The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system?
9. Disruption of circadian rhythms promotes alcohol use: a systematic review.
10. Evaluating the Readability of Online Patient Facing Resources for Alcohol Use Disorder
11. Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use Disorders
12. Opioid use and stigma: The role of gender, language and precipitating events
13. A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers
14. Evaluating the readability of online patient-facing resources for alcohol use disorder
15. Towards Personalized Treatments for Alcohol Use Disorder: a Focus on α1-blockade
16. Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin
17. Noradrenergic targets for the treatment of alcohol use disorder
18. Utilizing precision medicine to treat alcohol use disorder: A commentary on the α1 receptor antagonist
19. COVID-19-Related Stressors and Clinical Mental Health Symptoms in a Northeast US Sample
20. Mifepristone as a pharmacological intervention for stress-Induced alcohol craving: a translational crossover randomized trial
21. Mifepristone as a pharmacological intervention for stress‐induced alcohol craving: A human laboratory study.
22. The multitarget FAAH inhibitor/D3 partial agonist ARN15381 decreases nicotine self-administration in male rats
23. Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: Exploratory findings
24. The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder
25. Disruption of Circadian Rhythms Promotes Alcohol Use
26. Corticotropin Releasing Factor Binding Protein as a Novel Target to Restore Brain Homeostasis: Lessons Learned From Alcohol Use Disorder Research
27. Association of Substance Use With Behavioral Adherence to Centers for Disease Control and Prevention Guidelines for COVID-19 Mitigation: Cross-sectional Web-Based Survey
28. An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder
29. Pharmacological Approaches to Reducing Craving in Patients with Alcohol Use Disorders
30. Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial
31. Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorder
32. Effects of Idazoxan on Alcohol Pharmacokinetics and Intoxication: A Preliminary Human Laboratory Study
33. Relationship Between the Thyroid Axis and Alcohol Craving
34. Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic
35. Association of Substance Use With Behavioral Adherence to Centers for Disease Control and Prevention Guidelines for COVID-19 Mitigation: Cross-sectional Web-Based Survey (Preprint)
36. Pharmacotherapy for alcoholic patients with alcoholic liver disease
37. Ondansetron Reduces Naturalistic Drinking in Nontreatment-Seeking Alcohol-Dependent Individuals with the LL 5′-HTTLPR Genotype: A Laboratory Study
38. Neuroendocrine Response to Exogenous Ghrelin Administration, Combined With Alcohol, in Heavy-Drinking Individuals: Findings From a Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study
39. Andrographis paniculata and Its Main Bioactive Ingredient Andrographolide Decrease Alcohol Drinking and Seeking in Rats Through Activation of Nuclear PPARγ Pathway
40. Some Alcohol-Related Consequences for Women May Signal an Escape from Interpersonal Violence
41. Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β-Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders.
42. New Microglial Mechanisms Revealed in Alcohol Use Disorder: How Does That Translate?
43. Differences in Sociodemographic and Alcohol‐Related Clinical Characteristics Between Treatment Seekers and Nontreatment Seekers and Their Role in Predicting Outcomes in the COMBINE Study for Alcohol Use Disorder
44. A Combined Alcohol and Smoking Cue-Reactivity Paradigm in People Who Drink Heavily and Smoke Cigarettes: Preliminary Findings
45. Translational dynamics of alcohol tolerance of preclinical models and human laboratory studies.
46. Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β‐Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders
47. Protein Tyrosine Phosphatase β/ζ and Alcohol Use Disorder: A Commentary
48. Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use Disorder
49. Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study
50. Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.